Deal Watch: Oncology A Recurring Theme In Recent Spate Of Transactions

 
• By Jessica Merrill, Lisa LaMotta, and Sten Stovall

TetraLogic uses cash from its recent IPO to bring form to its oncology pipeline via the acquisition of Shape Pharmaceuticals. Also, GlaxoSmithKline becomes the latest big pharma to partner with MD Anderson Cancer Center’s Moon Shots program and Mersana will collaborate with Takeda on antibody-drug conjugates for cancer.

More from Archive

More from Pink Sheet